10 Sep RSV Vaccine Savings for Your OB/Gyn Practice
Pfizer is offering preferred pricing to PAA members on ABRYSVO. ABRYSVO is the only maternal RSV vaccine—CDC-recommended and ACOG-supported—for immunization of pregnant people between 32 weeks and 36 weeks gestation for the prevention of lower respiratory tract disease (LRTD) and severe LRTD caused by respiratory syncytial virus (RSV) in infants from birth through 6 months of age.
Log in now to learn more about the discount.
Not a member? Join today.